Tianjin TEDA Biomedical Engineering Co 8189.HK · HKD

Its shares trade on HKEX under the ticker 8189.HK. It has been listed since 18 June 2002. In the fiscal year to 31 December 2025, it reported revenue of CN¥509.4m and a net loss of CN¥88.5m. At that date it held total assets of CN¥265.0m and shareholders' equity of CN¥12.2m.

Tianjin TEDA Biomedical Engineering Co. Ltd. provides research, development and commercialization of compound fertilizer and health care products. The company is headquartered in Tianjin, Tianjin. The company went IPO on 2002-06-18. Its primary products include the series of biological compound fertilizer products for the promotion of balanced growth of grains, fruits and vegetables. These products are mainly sold under the brand of Fulilong. The Company’s businesses are mainly conducted in the People’s Republic of China (the PRC). The Company’s principal subsidiaries include Shandong Hidersun Fertiliser Industry Co., Ltd. and Guangdong Fulilong Compound Fertiliser Co., Ltd.

Figures and description from our data supplier, not checked against the company's own report.

• Ms. Li SunExecutive Chairman of the Board, Chief Executive Officer, since 2024
• Xin HeExecutive Director
• Ka Kuen NgCompany Secretary, Qualified AccountantCN¥150,000
• Ms. Aixin CaoNon-Executive Director
• Ximing LiNon-Executive Director
• Ms. Xueying LiNon-Executive Director
• Chun GaoNon-Executive Independent Director
• Mr. Xiangzhen TuIndependent Non-Executive Director
• Mr. Yongkang WangNon-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.